Abstract:Diffuse intrinsic pontine glioma (DIPG) is an infiltrative neoplasm with the highest mortality rate of all pediatric solid tumors. Recurrent somatic mutations of histone H3 isoforms result in methionine for lysine substitution (H3K27M) in 80% of DIPGs, thought to contribute to tumorigenesis via altered chromatin structure and function. To characterize the effects of the H3K27M mutation on gene expression, we analyzed the transcriptomes of rare DIPG primary cell lines with three distinct bioinformatics approaches. H3K27M DIPG (n=7), wild-type pediatric high-grade glioma (HGG, n=3), neural stem cells (n=1) and astrocytes (n=1) were analyzed (RNASeq, 50bp single end, Illumina NexSeq 500) in triplicate (36 runs). Reads were trimmed from 3’ to a final base quality score >30 (Trimmomatic), aligned to the human genome (UCSC hg19, Tophat), then normalized and quantified for 1) specific gene locus (GRanges), 2) exons of a specific gene locus (HTSeq), and 3) alternative splicing isoforms (Rsem). Differential expression was quantified (edgeR), with functional analyses for biological relevance of data sets (TopGO, Ingenuity Pathways Analysis). Epigenetic regulation of transcription, including increased EZH2 function (FC>5, p<0.05), SMARC4A inactivation (z-score >2), and Polymerase II activity at proximal promoter and enhancer regions (p>0.01), were identified in H3K27M mutant lines. Neurogenesis and neuronal differentiation were downregulated in H3K27M lines, consistent with morphologic changes observed in DIPG cell lines after EZH2 and BRD inhibition. Unsupervised clustering of GRanges and HTSeq demonstrated two DIPG subgroups, distinct from wild type and control lines. Rsem data demonstrates similar clustering of DIPGs, with less overlap of HGGs. We present novel transcriptome analysis of rare DIPG cell lines, indicating specific genes and signaling pathways that may promote tumor formation in the presence of H3K27M mutation. These data will be integrated with ChIP-Seq to correlate potential epigenetic mechanisms of aberrant transcriptional regulation secondary to H3K27M mutation.

Context-dependent Tumor-Suppressive BMP Signaling in Diffuse Intrinsic Pontine Glioma Regulates Stemness Through Epigenetic Regulation of CXXC5

DIPG-50. INSIGHTS INTO TUMORIGENESIS OF DIFFUSE INTRINSIC PONTINE GLIOMA-ONCOHISTONE AND SIGNALING

DIPG-39. ONCOHISTONE H3.3K27M-DRIVEN CREB5/ID1 AXIS DICTATES THE MALIGNANT CELL STATES OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

DIPG-14. INTEGRATED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) NEXT-GENERATION SEQUENCING REVEALS EPIGENETIC DYSREGULATION OF GENE EXPRESSION AND BROMODOMAIN INHIBITION AS A NOVEL THERAPEUTIC TARGET

Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma

Csig-26. Targeting Epigenetic Dysregulation And Adaptive Resistance Mechanisms In Dipg/Dmg

Next-Generation Sequencing Of Diffuse Intrinsic Pontine Glioma Cells Reveals Altered Epigenetic Regulation And Distinct Tumor Subgroups

H3.3 K27M Depletion Increases Differentiation and Extends Latency of Diffuse Intrinsic Pontine Glioma Growth in Vivo

Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma

DIPG-68. ONCOGENIC MECHANISMS OF H3.3 K27M IN A SPONTANEOUS DIPG MOUSE MODEL

BMP signaling in cancer stemness and differentiation

DIPG-13. A NOVEL MOUSE MODEL REVEALS UNEXPECTED MECHANISMS OF ACTION OF ACVR1 MUTATIONS IN DIFFUSE INTRINSIC PONTINE GLIOMA

Diffuse Intrinsic Pontine Gliomas Exhibit Cell Biological and Molecular Signatures of Fetal Hindbrain-Derived Neural Progenitor Cells

Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG

DIPG-41. IDENTIFICATION OF BIRC5 AS A NOVEL THERAPEUTIC TARGET FOR DIFFUSE INTRINSIC PONTINE GLIOMA

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas

PDTM-39. CRACKING THE HISTONE CODE: REVEALING THERAPEUTIC EPIGENETIC TARGETS THROUGH HISTONE H3 TAIL ANALYSIS OF DIFFUSE INTRINSIC PONTINE GLIOMA

DIPG-34. SUPER ELONGATION COMPLEX AS A TARGETABLE DEPENDENCY IN H3K27M+ DIFFUSE MIDLINE GLIOMA

Potent Anti-Tumor Efficacy of Palbociclib in Treatment-Naïve H3.3K27M-mutant Diffuse Intrinsic Pontine Glioma.

Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression.